Related Experiment Video
Updated: May 23, 2026
08:47
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Anti-oncogenic potential of the eIF4E-binding proteins.
Y Martineau1, R Azar, C Bousquet
1INSERM UMR-1037, Université de Toulouse, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France.
Oncogene
|April 18, 2012
Summary
eIF4E-binding proteins (4E-BPs) inhibit protein synthesis and block cancer cell growth. Their function is often disrupted in tumors, but they show therapeutic potential as cancer drug targets.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- eIF4E-binding proteins (4E-BPs) are crucial inhibitors of protein synthesis.
- They sequester the mRNA cap-binding protein eIF4E, thereby blocking cell growth and proliferation.
- In many tumors, the inhibitory function of 4E-BPs is impaired by oncogenic signaling pathways.
Purpose of the Study:
- To review the biochemical function and regulation of 4E-BPs.
- To elucidate the involvement of 4E-BPs and eIF4E in carcinogenesis.
- To highlight the anti-oncogenic activity and therapeutic potential of 4E-BPs in cancer.
Main Methods:
- Literature review of biochemical and genetic studies.
- Analysis of mouse genetic models elucidating 4E-BP and eIF4E roles in cancer.
- Summary of evidence on protein synthesis addiction in cancer cells.
Main Results:
- 4E-BPs are key regulators of protein synthesis, controlling cell growth.
- Oncogenic pathways frequently disrupt 4-BP function in tumors.
- Mouse models have advanced understanding of 4E-BP involvement in carcinogenesis.
Conclusions:
- Cancer cells often exhibit an 'addiction' to high rates of protein synthesis.
- 4E-BPs represent promising therapeutic targets for cancer treatment.
- Understanding 4E-BP regulation and function is critical for developing novel anti-cancer strategies.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.